Hospitalization and supportive care medication (SCM) utilisation in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCAm) in EMBRACA
Document type:
Meeting Abstract
Author(s):
Ettl, J.; Quek, R. G. W.; Hurvitz, S. A.; Goncalves, A.; Tudor, I. C.; Rugo, H. S.